Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Prostate Cancer

  Free Subscription


2 AJR Am J Roentgenol
1 Am J Hum Genet
3 BJU Int
1 BMC Cancer
1 BMC Urol
5 Br J Cancer
1 Br J Radiol
1 Cancer
2 Eur Urol
1 Hum Pathol
2 J Clin Lab Anal
3 N Engl J Med
1 Oncogene
3 Prostate
1 Radiol Imaging Cancer
2 Urol Int

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    AJR Am J Roentgenol

  1. HUANG YH, Ozutemiz C, Rubin N, Schat R, et al
    Impact of 18 French Rectal Tube Placement on Image Quality of Multiparametric Prostate MRI.
    AJR Am J Roentgenol. 2021 Apr 14. doi: 10.2214/AJR.21.25732.
    PubMed         Abstract available

  2. GAN JM, Kikano EG, Smith DA, Rao S, et al
    Clinically Significant Prostate Cancer Detection After A Negative Prebiopsy MRI Examination: Comparison of Biparametric Versus Multiparametric MRI.
    AJR Am J Roentgenol. 2021 Nov 24. doi: 10.2214/AJR.21.26569.
    PubMed         Abstract available

    Am J Hum Genet

  3. GIAMBARTOLOMEI C, Seo JH, Schwarz T, Freund MK, et al
    H3K27ac HiChIP in prostate cell lines identifies risk genes for prostate cancer susceptibility.
    Am J Hum Genet. 2021 Nov 22. pii: S0002-9297(21)00419.
    PubMed         Abstract available

    BJU Int

  4. LEE V, An Y, Park HS, Yu JB, et al
    Emergency Department Visits for Radiation Cystitis Among Patients with a Prostate Cancer History.
    BJU Int. 2021 Nov 22. doi: 10.1111/bju.15650.
    PubMed         Abstract available

  5. ROSENBERG JE, Jung JH, Lee H, Lee S, et al
    Posterior musculofascial reconstruction in robotic-assisted laparoscopic prostatectomy for the treatment of clinically localized prostate cancer: a Cochrane Review.
    BJU Int. 2021 Nov 26. doi: 10.1111/bju.15657.
    PubMed         Abstract available

  6. JOHN JB, Pascoe J, Fowler S, Walton T, et al
    A nationwide trend away from radical prostatectomy for Gleason grade group 1 prostate cancer.
    BJU Int. 2021 Nov 26. doi: 10.1111/bju.15656.
    PubMed         Abstract available

    BMC Cancer

  7. LIN E, Garmo H, Van Hemelrijck M, Adolfsson J, et al
    Exploring the association between use of gonadotropin releasing hormones agonists and prostate cancer diagnosis per se and diabetes control in men with type 2 diabetes mellitus: a nationwide, population-based cohort study.
    BMC Cancer. 2021;21:1259.
    PubMed         Abstract available

    BMC Urol

  8. HSIEH PF, Li TR, Lin WC, Chang H, et al
    Combining prostate health index and multiparametric magnetic resonance imaging in estimating the histological diameter of prostate cancer.
    BMC Urol. 2021;21:161.
    PubMed         Abstract available

    Br J Cancer

  9. NA R, Wei J, Sample CJ, Gielzak M, et al
    The HOXB13 variant X285K is associated with clinical significance and early age at diagnosis in African American prostate cancer patients.
    Br J Cancer. 2021 Nov 19. pii: 10.1038/s41416-021-01622.
    PubMed         Abstract available

  10. RAMIREZ-GARRASTACHO M, Bajo-Santos C, Line A, Martens-Uzunova ES, et al
    Extracellular vesicles as a source of prostate cancer biomarkers in liquid biopsies: a decade of research.
    Br J Cancer. 2021 Nov 22. pii: 10.1038/s41416-021-01610.
    PubMed         Abstract available

  11. RAMIREZ-GARRASTACHO M, Berge V, Line A, Llorente A, et al
    Potential of miRNAs in urinary extracellular vesicles for management of active surveillance in prostate cancer patients.
    Br J Cancer. 2021 Nov 22. pii: 10.1038/s41416-021-01598.
    PubMed         Abstract available

  12. WEN YC, Liu CL, Yeh HL, Chen WH, et al
    PCK1 regulates neuroendocrine differentiation in a positive feedback loop of LIF/ZBTB46 signalling in castration-resistant prostate cancer.
    Br J Cancer. 2021 Nov 24. pii: 10.1038/s41416-021-01631.
    PubMed         Abstract available

  13. HATANO K, Yoneyama T, Hatakeyama S, Tomiyama E, et al
    Simultaneous analysis of serum alpha2,3-linked sialylation and core-type fucosylation of prostate-specific antigen for the detection of high-grade prostate cancer.
    Br J Cancer. 2021 Nov 20. pii: 10.1038/s41416-021-01637.
    PubMed         Abstract available

    Br J Radiol

  14. COLE AP, Langbein BJ, Giganti F, Fennessy FM, et al
    Is perfect the enemy of good? Weighing the evidence for biparametric MRI in prostate cancer.
    Br J Radiol. 2021 Nov 26:20210840. doi: 10.1259/bjr.20210840.
    PubMed         Abstract available


  15. JAVIER-DESLOGES J, Nelson TJ, Murphy JD, McKay RR, et al
    Disparities and trends in the participation of minorities, women, and the elderly in breast, colorectal, lung, and prostate cancer clinical trials.
    Cancer. 2021 Nov 22. doi: 10.1002/cncr.33991.
    PubMed         Abstract available

    Eur Urol

  16. SO WZ, Wang Z, Tiong HY
    Re: Anna Lantz, David Bock, Olof Akre, et al. Functional and Oncological Outcomes After Open Versus Robot-assisted Laparoscopic Radical Prostatectomy for Localised Prostate Cancer: 8-Year Follow-up. Eur Urol 2021;80:650-60.
    Eur Urol. 2021 Nov 22. pii: S0302-2838(21)02140.

  17. IMMERZEEL J, Israel B, Bomers J, Schoots IG, et al
    Multiparametric Magnetic Resonance Imaging for the Detection of Clinically Significant Prostate Cancer: What Urologists Need to Know. Part 4: Transperineal Magnetic Resonance-Ultrasound Fusion Guided Biopsy Using Local Anesthesia.
    Eur Urol. 2021 Nov 16. pii: S0302-2838(21)02135.
    PubMed         Abstract available

    Hum Pathol

  18. COLLINS K, Brocken E, Bahler CD, Alabd A, et al
    High Intensity Focused Ultrasound for the Treatment of Prostate Cancer: Assessing Location of Failure after Focal Therapy in Prostate Cancer and Review of Histological Characteristics and Clinicopathologic Correlates after Treatment: A 5-Year Experien
    Hum Pathol. 2021 Nov 18. pii: S0046-8177(21)00194.
    PubMed         Abstract available

    J Clin Lab Anal

  19. SAID R, Jenni R, Boussetta S, Ammous F, et al
    Association of a common genetic variant (insertion/deletion) in ACE gene with prostate cancer susceptibility in a Tunisian population.
    J Clin Lab Anal. 2021 Nov 19:e24129. doi: 10.1002/jcla.24129.
    PubMed         Abstract available

  20. SHAN J, Liu Z, Geng X, Feng Y, et al
    The influence of age on prostate cancer screening index.
    J Clin Lab Anal. 2021 Nov 24:e24098. doi: 10.1002/jcla.24098.
    PubMed         Abstract available

    N Engl J Med

  21. EKLUND M, Discacciati A, Nordstrom T
    MRI-Targeted Biopsy in Prostate Cancer Screening. Reply.
    N Engl J Med. 2021;385:2110-2111.

  22. YOSHIDA S, Fujii Y
    MRI-Targeted Biopsy in Prostate Cancer Screening.
    N Engl J Med. 2021;385:2110.

  23. AL HUSSEIN AL AWAMLH B, Spratt DE, Shoag JE
    MRI-Targeted Biopsy in Prostate Cancer Screening.
    N Engl J Med. 2021;385:2109-2110.


  24. MAZZU YZ, Liao YR, Nandakumar S, Jehane LE, et al
    Prognostic and therapeutic significance of COP9 signalosome subunit CSN5 in prostate cancer.
    Oncogene. 2021 Nov 20. pii: 10.1038/s41388-021-02118.
    PubMed         Abstract available


  25. PREISSER F, Wurnschimmel C, Pose RM, Heinze A, et al
    Concordance of biopsy and pathologic ISUP grading in salvage radical prostatectomy patients for recurrent prostate cancer.
    Prostate. 2021 Nov 22. doi: 10.1002/pros.24268.
    PubMed         Abstract available

  26. VESTRIS PG, Gourtaud G, Senechal C, Sadreux Y, et al
    Overall and progression-free survival of Afro-Caribbean men with metastatic castration-resistant prostate cancer (mCRPC).
    Prostate. 2021 Nov 25. doi: 10.1002/pros.24270.
    PubMed         Abstract available

  27. PLAMBECK BD, Wang LL, Mcgirr S, Jiang J, et al
    Effects of the 2012 and 2018 US preventive services task force prostate cancer screening guidelines on pathologic outcomes after prostatectomy.
    Prostate. 2021 Nov 22. doi: 10.1002/pros.24261.
    PubMed         Abstract available

    Radiol Imaging Cancer

    Radioligand Therapy for Metastatic Prostate Cancer.
    Radiol Imaging Cancer. 2021;3:e219026.

    Urol Int

  29. FLEGAR L, Baunacke M, Buerk BT, Proschmann R, et al
    Decision Regret and Quality of Life after Focal Therapy with Vascular-Targeted Photodynamic Therapy (TOOKAD(R)) for Localized Prostate Cancer.
    Urol Int. 2021 Nov 23:1-6. doi: 10.1159/000520084.
    PubMed         Abstract available

  30. GUO Y, Tian Y, Deng Y, Lu C, et al
    Diagnostic Performance of [18F]-Labeled PET/CT Tracers for Lymph Node/Bone Metastasis and Biochemical Recurrence Detection in Advanced Prostate Cancer: A Meta-Analysis.
    Urol Int. 2021 Oct 13:1-19. doi: 10.1159/000518478.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Prostate Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.